// App-Quantinova.ai

3772 : SHP-1 determines the radiosensitivity of liver cancer cell and dovitinib acts as a novel radiosensitizer in hepatocellular carcinoma via targeting SHP-1/STAT3 signaling

Researchers

Presenter

  • Man-Hsin Hung

Principal Investigators

  • Chao-Yuan Huang

  • Wei-Tien Tai

  • Ming-Hsien Tsai

  • Chih-Ting Shin

  • Szu-Yuan Wu

  • Chung-Wai Shiau

  • Kuen-Feng Chen

Medical Centers

  • Wan Fang Hospital, Taipei, Taiwan

  • National Yang-Ming University, Taipei, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Signal transducer and activator of transcription 3

  • Src homology region 2 domain-containing phosphatase-1

Drug/Treatment

  • Dovitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved